TGLVY
Price
$0.50
Change
-$0.06 (-10.71%)
Updated
Nov 18 closing price
Capitalization
1.15B
Intraday BUY SELL Signals
VPTDF
Price
$0.07
Change
-$0.00 (-0.00%)
Updated
Nov 18 closing price
Capitalization
10.68M
Intraday BUY SELL Signals
Interact to see
Advertisement

TGLVY vs VPTDF

Header iconTGLVY vs VPTDF Comparison
Open Charts TGLVY vs VPTDFBanner chart's image
Top Glove
Price$0.50
Change-$0.06 (-10.71%)
Volume$1.17K
Capitalization1.15B
VentriPoint Diagnostics
Price$0.07
Change-$0.00 (-0.00%)
Volume$22.69K
Capitalization10.68M
TGLVY vs VPTDF Comparison Chart in %
TGLVY
Daily Signal:
Gain/Loss:
VPTDF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
TGLVY vs. VPTDF commentary
Nov 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TGLVY is a Hold and VPTDF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 19, 2025
Stock price -- (TGLVY: $0.50 vs. VPTDF: $0.07)
Brand notoriety: TGLVY and VPTDF are both not notable
TGLVY represents the Pharmaceuticals: Other, while VPTDF is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: TGLVY: 47% vs. VPTDF: 65%
Market capitalization -- TGLVY: $1.15B vs. VPTDF: $10.68M
TGLVY [@Pharmaceuticals: Other] is valued at $1.15B. VPTDF’s [@Medical/Nursing Services] market capitalization is $10.68M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $193.83B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $226.05B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.71B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TGLVY’s FA Score shows that 1 FA rating(s) are green whileVPTDF’s FA Score has 0 green FA rating(s).

  • TGLVY’s FA Score: 1 green, 4 red.
  • VPTDF’s FA Score: 0 green, 5 red.
According to our system of comparison, TGLVY is a better buy in the long-term than VPTDF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TGLVY’s TA Score shows that 3 TA indicator(s) are bullish while VPTDF’s TA Score has 3 bullish TA indicator(s).

  • TGLVY’s TA Score: 3 bullish, 7 bearish.
  • VPTDF’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, both TGLVY and VPTDF are a bad buy in the short-term.

Price Growth

TGLVY (@Pharmaceuticals: Other) experienced а -1.06% price change this week, while VPTDF (@Medical/Nursing Services) price change was -6.69% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.04%. For the same industry, the average monthly price growth was -0.03%, and the average quarterly price growth was +8.71%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -4.85%. For the same industry, the average monthly price growth was -7.90%, and the average quarterly price growth was +10.84%.

Industries' Descriptions

@Pharmaceuticals: Other (-2.04% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-4.85% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TGLVY($1.15B) has a higher market cap than VPTDF($10.7M). VPTDF YTD gains are higher at: -3.723 vs. TGLVY (-55.860). TGLVY has higher annual earnings (EBITDA): 482M vs. VPTDF (-4.43M). TGLVY has more cash in the bank: 561M vs. VPTDF (353K). VPTDF has less debt than TGLVY: VPTDF (2.13M) vs TGLVY (850M). TGLVY has higher revenues than VPTDF: TGLVY (3.49B) vs VPTDF (166K).
TGLVYVPTDFTGLVY / VPTDF
Capitalization1.15B10.7M10,785%
EBITDA482M-4.43M-10,869%
Gain YTD-55.860-3.7231,500%
P/E Ratio38.25N/A-
Revenue3.49B166K2,101,807%
Total Cash561M353K158,924%
Total Debt850M2.13M39,944%
FUNDAMENTALS RATINGS
TGLVY vs VPTDF: Fundamental Ratings
TGLVY
VPTDF
OUTLOOK RATING
1..100
6221
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
100
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
85100
PRICE GROWTH RATING
1..100
8180
P/E GROWTH RATING
1..100
9575
SEASONALITY SCORE
1..100
n/a20

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TGLVY's Valuation (24) in the null industry is significantly better than the same rating for VPTDF (100). This means that TGLVY’s stock grew significantly faster than VPTDF’s over the last 12 months.

TGLVY's Profit vs Risk Rating (100) in the null industry is in the same range as VPTDF (100). This means that TGLVY’s stock grew similarly to VPTDF’s over the last 12 months.

TGLVY's SMR Rating (85) in the null industry is in the same range as VPTDF (100). This means that TGLVY’s stock grew similarly to VPTDF’s over the last 12 months.

VPTDF's Price Growth Rating (80) in the null industry is in the same range as TGLVY (81). This means that VPTDF’s stock grew similarly to TGLVY’s over the last 12 months.

VPTDF's P/E Growth Rating (75) in the null industry is in the same range as TGLVY (95). This means that VPTDF’s stock grew similarly to TGLVY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TGLVYVPTDF
RSI
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 7 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
71%
Bullish Trend 10 days ago
68%
Declines
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 21 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
TGLVY
Daily Signal:
Gain/Loss:
VPTDF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SVIIX10.08N/A
N/A
Virtus Ceredex Large-Cap Value Equity A
KTCCX16.01N/A
N/A
DWS Science and Technology C
GCEUX102.33N/A
N/A
Green Century Equity Institutional
WCMLX13.04N/A
N/A
WCM Small Cap Growth Institutional
JHUJX38.88-0.35
-0.89%
JPMorgan Emerging Markets Equity R2

TGLVY and

Correlation & Price change

A.I.dvisor tells us that TGLVY and BNR have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TGLVY and BNR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TGLVY
1D Price
Change %
TGLVY100%
-10.14%
BNR - TGLVY
20%
Poorly correlated
-6.15%
SSMXY - TGLVY
12%
Poorly correlated
-0.31%
VPTDF - TGLVY
8%
Poorly correlated
-6.69%
TRUMY - TGLVY
3%
Poorly correlated
-2.09%
SUVPF - TGLVY
2%
Poorly correlated
N/A
More

VPTDF and

Correlation & Price change

A.I.dvisor tells us that VPTDF and TWST have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VPTDF and TWST's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VPTDF
1D Price
Change %
VPTDF100%
-6.69%
TWST - VPTDF
21%
Poorly correlated
-1.74%
OM - VPTDF
14%
Poorly correlated
+0.91%
TLTFF - VPTDF
13%
Poorly correlated
-1.00%
TGLVY - VPTDF
8%
Poorly correlated
-10.14%
WILYY - VPTDF
7%
Poorly correlated
N/A
More